Related Experiment Videos
[Lymphoid myelofibrosis or hairy cell leukemia]
Minerva Medica
|May 26, 1977
Summary
Hairy cell leukaemia is a rare blood disorder characterized by unique "hairy" lymphocytes. Splenectomy is the primary treatment for this condition.
Area of Science:
- Hematology
- Oncology
Background:
- Hairy cell leukaemia (HCL) is a rare lymphoproliferative disorder.
- It is characterized by specific lymphocyte morphology and clinical presentation.
Observation:
- The defining feature of HCL is the presence of lymphocyte-type cells with villous projections, termed 'hairy cells'.
- Clinically, HCL typically manifests as myelopathy with splenomegaly, often without significant lymphadenopathy.
Findings:
- The origin of hairy cells is debated, with theories suggesting derivation from monocytes, histiocytes, or B lymphocytes.
- A reported case exemplifies typical clinical and laboratory features of HCL.
Implications:
- Understanding the nature of hairy cells is crucial for accurate diagnosis and classification.
- Splenectomy is widely accepted as the most effective therapeutic intervention for HCL.
- Reclassification of certain atypical leukaemias and lymphomas as HCL may be warranted.